288 related articles for article (PubMed ID: 15916184)
1. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
Trent JT; Kerdel FA
Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
[TBL] [Abstract][Full Text] [Related]
2. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
Poulin Y
J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
LaDuca JR; Gaspari AA
Dermatol Clin; 2001 Oct; 19(4):617-35. PubMed ID: 11705350
[TBL] [Abstract][Full Text] [Related]
5. TNF-α antagonists beyond approved indications: stories of success and prospects for the future.
Karampetsou MP; Liossis SN; Sfikakis PP
QJM; 2010 Dec; 103(12):917-28. PubMed ID: 20802008
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum and tumor necrosis factor α agents.
Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
[No Abstract] [Full Text] [Related]
7. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
Sockolov ME; Alikhan A; Zargari O
J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
[TBL] [Abstract][Full Text] [Related]
8. Off-label dermatologic uses of anti-TNF-a therapies.
Alexis AF; Strober BE
J Cutan Med Surg; 2005 Dec; 9(6):296-302. PubMed ID: 16699906
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
Haslund P; Lee RA; Jemec GB
Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
[TBL] [Abstract][Full Text] [Related]
10. Cytokine blocking agents in dermatology.
Williams JD; Griffiths CE
Clin Exp Dermatol; 2002 Oct; 27(7):585-90. PubMed ID: 12464154
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
12. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.
van Rappard DC; Limpens J; Mekkes JR
J Dermatolog Treat; 2013 Oct; 24(5):392-404. PubMed ID: 22397574
[TBL] [Abstract][Full Text] [Related]
13. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
Weinberg JM; Saini R
Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
[TBL] [Abstract][Full Text] [Related]
14. Impact of TNF-α antagonists on the quality of life in selected skin diseases.
Gisondi P; Girolomoni G
G Ital Dermatol Venereol; 2013 Jun; 148(3):243-8. PubMed ID: 23670060
[TBL] [Abstract][Full Text] [Related]
15. Long-term management of erythrodermic psoriasis with anti-TNF agents.
Romero-Maté A; García-Donoso C; Martinez-Morán C; Hernández-Núñez A; Borbujo J
Dermatol Online J; 2010 Jun; 16(6):15. PubMed ID: 20579470
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
17. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
Calamia KT
Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
[No Abstract] [Full Text] [Related]
18. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
Shuja F; Chan CS; Rosen T
Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
Brunasso AM; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
[No Abstract] [Full Text] [Related]
20. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]